Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker-Reference-Cited by-同舟云学术

Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker

Published:2005-01 Issue:1 Volume:96 Page:77-83
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Huddleston Heather G.,Wong Kwong-kwok,Welch William R.,Berkowitz Ross S.,Mok Samuel C.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference18 articles.

1. Cancer facts and figures;American Cancer Society,2003

2. SEER Cancer Statistics Review 1973–1995;Ries,1998

3. Expression profiling using cDNA microarrays;Duggan;Nat. Genet.,1999

4. Quantitative monitoring of gene expression patterns with a complementary DNA microarray;Schena;Science,1995

5. Prostasin is an upregulated gene in epithelial ovarian cancer with potential as a serum marker identified through microarray technology;Mok;J. Natl. Cancer. Inst.,2001

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer;Journal of Extracellular Vesicles;2024-03

2. Machine learning-based prediction model and visual interpretation for prostate cancer;BMC Urology;2023-10-14

3. Proteomics approaches in the identification of cancer biomarkers and drug discovery;Proteomics;2023

4. Optical-based biosensor for detection of oncomarker CA 125, recent progress and current status;Analytical Biochemistry;2022-10

5. Cytochalasin Q exerts anti-melanoma effect by inhibiting creatine kinase B;Toxicology and Applied Pharmacology;2022-04